摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 | 3353-33-1

中文名称
[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯
中文别名
——
英文名称
[3']guanylic acid guanosin-5'-yl ester
英文别名
GpG;Guanylyl-(3'-5')-guanosine;[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯化学式
CAS
3353-33-1
化学式
C20H25N10O12P
mdl
——
分子量
628.452
InChiKey
MNXLMHSUERRXOE-MHARETSRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.8
  • 重原子数:
    43
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    326
  • 氢给体数:
    9
  • 氢受体数:
    16

SDS

SDS:07341ace24a6d9075125b88e45a16f07
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Rapid and highly base selective RNA cleavage by a dinuclear Cu(II) complex
    作者:Shanghao Liu、Andrew D. Hamilton
    DOI:10.1039/a808195f
    日期:——
    A bis-Cu(II) complex based on a covalently linked terpyridine and bipyridine ligand system is shown to rapidly cleave bis-ribonucleotides with remarkable selectivity for adenine bases.
    基于共价连接的吡啶并三吡啶和联吡啶配体系统的二铜(II)配合物,显示出对腺嘌呤基具有显著选择性的双核糖核酸快速切割能力。
  • Dinuclear Zn<sup>2+</sup>complexes in the hydrolysis of the phosphodiester linkage in a diribonucleoside monophosphate diester
    作者:Morio Yashiro、Hideki Kaneiwa、Kenichi Onaka、Makoto Komiyama
    DOI:10.1039/b312301d
    日期:——
    Dizinc complexes that were formed from 2 ∶ 1 mixtures of Zn(NO3)2 and dinucleating ligands TPHP (1), TPmX (2) or TPpX (3) in aqueous solutions efficiently hydrolyzed diribonucleoside monophosphate diesters (NpN) under mild conditions. The dinucleating ligand affected the structure of the aquo-hydroxo-dizinc core, resulting in different characteristics in the catalytic activities towards NpN cleavage. The pH-rate profile of ApA cleavage in the presence of (Zn2+)2-1 was sigmoidal, whereas those of (Zn2+)2-2 and (Zn2+)2-3 were bell-shaped. The pH titration study indicated that (Zn2+)2-1 dissociates only one aquo proton (up to pH 12), whereas (Zn2+)2-2 dissociates three aquo protons (up to pH 10.7). The observed differences in the pH-rate profile are attributable to the various distributions of the monohydroxo-dizinc species, which are responsible for NpN cleavage. As compared to that using (Zn2+)2-1, the NpN cleavage using (Zn2+)2-2 showed a greater rate constant, with a higher product ratio of 3′-NMP/2′-NMP. The saturation behaviors of the rate, with regard to the concentration of NpN, were analyzed by Michaelis–Menten type kinetics. Although the binding of (Zn2+)2-2 to ApA was weaker than that of (Zn2+)2-1, (Zn2+)2-2 showed a greater kcat value than (Zn2+)2-1, resulting in higher ApA cleavage activity of the former.
    由2:1的Zn(NO3)2与双配体TPHP(1)、TPmX(2)或TPpX(3)在水溶液中形成的二锌复合物在温和条件下有效水解二核苷酸单磷酸二酯(NpN)。双配体的结构影响了水合羟基二锌核心的构造,导致其催化NpN裂解的活性特征有所不同。在(Zn2+)2-1存在下,ApA裂解的pH-速率曲线呈S型,而(Zn2+)2-2和(Zn2+)2-3的曲线则呈钟形。pH滴定研究表明,(Zn2+)2-1仅在pH达到12时解离一个水合质子,而(Zn2+)2-2在pH达到10.7时则解离三个水合质子。观察到的pH-速率曲线差异可归因于单羟基二锌物种的不同分布,这些物种是NpN裂解的关键。与使用(Zn2+)2-1相比,使用(Zn2+)2-2时的NpN裂解表现出更大的速率常数,且3′-NMP/2′-NMP的产物比例更高。关于NpN浓度的速率饱和行为通过米氏动力学分析。尽管(Zn2+)2-2对ApA的结合强度弱于(Zn2+)2-1,但(Zn2+)2-2的kcat值高于(Zn2+)2-1,导致前者在ApA裂解中的活性更强。
  • Stabilization of monofunctional platinum–nucleotide adducts: reactions of N-acetyl-<scp>L</scp>-methionine complexes with guanosine 5′-monophosphate and guanylyl(3′–5′)guanosine
    作者:Kevin J. Barnham、Zijian Guo、Peter J. Sadler
    DOI:10.1039/dt9960002867
    日期:——
    [Pt(en)Cl2], whereas 2 was stable in water. The reaction of 1n with guanosine 5′-monophosphate (5′-GMP) gave a stable mixed-ligand complex [Pt([15N]en)MeCO-Met(1–)-S}(5′-GMP-N7)]+, and the reaction with guanylyl(3-5′)guanosine (GpG) gave two different monofunctional adducts [Pt([15N]en)MeCO-Met(1–)-S}(GpG-N7)]+, due to platination of either 3′- or 5′-G, with a preferential formation of one over the other
    [Pt(en)MeCO-Met- S)Cl] NO 3 1,[Pt(en)(MeCO-Met- S)2 ] [NO 3 ] 2 2(en =乙烷-1,2-二胺,已制备MeCO-Met = N-乙酰基-L-甲硫氨酸及其15 N类似物(1n和2n),并通过1 H,13 C和二维[ 1 H,15 N]光谱进行了表征。复合物1(在310 K下半衰期为3.9小时)的水解速度比[Pt(en)Cl 2 ]慢,而2在水中稳定。1n与鸟苷5'-单磷酸酯(5'-GMP)的反应产生了稳定的混合配体络合物[Pt([ 15 N] en)MeCO-Met(1 –)- S }(5'-GMP- N 7)] +,与鸟苷基(3'-5')鸟苷(GpG)的反应产生了两个不同的单官能团加合物[Pt([ 15 N] en)MeCO-Met(1 –)- S }(GpG- N 7)] +,由于3'-G或5'-G的电镀反应,优先形成一
  • Imprinting Structural Information from a GpG Ligand into the Configuration of a Chiral Diamine Ligand through Second-Sphere Communication in Platinum(II) Complexes
    作者:Kevin M. Williams、Tommaso Scarcia、Giovanni Natile、Luigi G. Marzilli
    DOI:10.1021/ic000067n
    日期:2001.1.1
    designated, for example, as R,R,R,R. This ligand has greater flexibility and more readily inverted N centers than ligands used previously in GpG retro models. One goal was to determine whether the GpG ligand can control the configuration of a carrier ligand. (R,R,R,R)-Me2DAPPt(GpG) forms the anti, anti HH1 R variant almost exclusively. Equal populations of the two possible linkage isomers of (S,R,R,R)-Me2DAPPt(GpG)
    顺铂与DNA形成顺式-Pt(NH3)2(d(GpG))交联。我们最近通过使用“复古模型”(具有旨在减慢d(GpG)动态运动的笨重载体配体的复合物)创建了新颖的d(GpG)构象。我们的结果定义了四个构象类别:HH1,HH2,δHT1和δHT2,具有头对头或头对尾的碱基方向,且磷酸二酯主链的传播方向为正常(1)或相反(2) 。此外,每个G残基可以是顺式或反式的,并且基本倾斜可以是左手(L)或右手(R)。因此,可以想到顺式-Pt(NH3)2(d(GpG))的32个变体,但加合物的动力学太动态而无法研究。到目前为止,通过使用逆向模型,我们获得了d(GpG)的五个变异体的证据,而GpG的只有四个变异体的证据。因此,我们选择Me2DAPPt(GpG)配合物用于1H和31P NMR光谱研究,CD光谱学以及分子力学和动力学(MMD)计算。配位的Me2DAP(N,N'-二甲基-2,4-二氨基戊烷)具有N,C
  • A Rare Example of Three Abundant Conformers in One Retro Model of the Cisplatin−DNA d(GpG) Intrastrand Cross Link. Unambiguous Evidence That Guanine O6 to Carrier Amine Ligand Hydrogen Bonding Is Not Important. Possible Effect of the Lippard Base Pair Step Adjacent to the Lesion on Carrier Ligand Hydrogen Bonding in DNA Adducts
    作者:Sharon T. Sullivan、Antonella Ciccarese、Francesco P. Fanizzi、Luigi G. Marzilli
    DOI:10.1021/ja010483m
    日期:2001.9.1
    hindering dynamic motion in Me(2)ppzPt(d(GpG)) and Me(2)ppzPt(GpG) retro models. Dynamic processes are decreased enough in Me(2)ppzPt(d(GpG)) to permit HPLC separation of three abundant forms. After HPLC separation, the three re-equilibrate, proving that the three forms must be conformers and that Me(2)ppz has little influence on conformer distribution. This marks the first reported characterization of three
    鸟嘌呤O6与载体配体的氢键结合是许多假设的主要特征,这些假设先进地解释了顺式抗癌药cis-PtA(2)X(2)(A(2)=二胺或两种胺)的抗癌活性。早期的结构证据表明,顺式-Pt(NH(3))(2)(d(GpG))(关键的顺铂-DNA加合物的交联模型)和其他顺式-PtA(2)(d(GpG)) )加合物专门或主要作为具有头对头(HH)碱基的HH1构象体存在。这些加合物中d(GpG)的动态运动太快,无法确定构象和H键的特征。因此,我们使用具有A(2)配体的复古模型来减慢运动。在这里,我们使用Me(2)ppz(N,N'-二甲基哌嗪),它缺少NH基团。Me(2)ppz的独特之处在于直接在配位平面中具有sp(3)N-甲基,允许多个构象元共存,但阻碍了Me(2)ppzPt(d(GpG))和Me(2)ppzPt(GpG)复古模型中的动态运动。Me(2)ppzPt(d(GpG))中的动态过程降低得足够少,
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine